Detailed information for compound 1737626

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 351.833 | Formula: C19H18ClN5
  • H donors: 1 H acceptors: 3 LogP: 3.96 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCNCc1ccc2c(c1)n1c(nnc1c(n2)C)c1ccccc1Cl
  • InChi: 1S/C19H18ClN5/c1-3-21-11-13-8-9-16-17(10-13)25-18(12(2)22-16)23-24-19(25)14-6-4-5-7-15(14)20/h4-10,21H,3,11H2,1-2H3
  • InChiKey: PMOYHZUHMRBKJN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens phosphodiesterase 2A, cGMP-stimulated Starlite/ChEMBL References
Rattus norvegicus cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum cGMP-dependent 3',5'-cyclic phosphodiesterase, putative Get druggable targets OG5_135549 All targets in OG5_135549
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363
Schistosoma japonicum ko:K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC3.1.4.17], putative Get druggable targets OG5_135549 All targets in OG5_135549
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein Get druggable targets OG5_135549 All targets in OG5_135549
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative Get druggable targets OG5_135363 All targets in OG5_135363
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase Get druggable targets OG5_135549 All targets in OG5_135549
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135549 All targets in OG5_135549
Schistosoma japonicum cGMP-dependent 3',5'-cyclic phosphodiesterase, putative Get druggable targets OG5_135549 All targets in OG5_135549

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 679 aa 26.7 %
Trypanosoma cruzi cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 665 aa 30.5 %
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 686 aa 24.1 %
Trypanosoma cruzi cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 668 aa 30.5 %
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 661 aa 22.7 %
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase phosphodiesterase 2A, cGMP-stimulated 934 aa 748 aa 27.1 %
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 682 aa 23.5 %
Leishmania infantum cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 671 aa 30.4 %
Echinococcus multilocularis dual 3',5' cyclic AMP and GMP phosphodiesterase cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 688 aa 29.1 %
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 682 aa 28.9 %
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 665 aa 23.5 %
Trypanosoma brucei gambiense cAMP-specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 666 aa 30.5 %
Leishmania braziliensis cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 674 aa 29.1 %
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 689 aa 22.8 %
Trypanosoma brucei cAMP-specific phosphodiesterase cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 661 aa 30.3 %
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 699 aa 25.5 %
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 683 aa 27.5 %
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 666 aa 29.1 %
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 693 aa 25.3 %
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 653 aa 23.0 %
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 655 aa 24.1 %
Leishmania donovani cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 671 aa 30.6 %
Leishmania mexicana cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 672 aa 30.2 %
Leishmania braziliensis cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 674 aa 29.2 %
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 689 aa 22.8 %
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 716 aa 26.0 %
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 671 aa 26.5 %
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 668 aa 25.7 %
Leishmania infantum cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 671 aa 30.6 %
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 711 aa 26.2 %
Trichomonas vaginalis cAMP/cGMP cyclic nucleotide phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 712 aa 25.0 %
Trypanosoma congolense cAMP-specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 656 aa 30.9 %
Trypanosoma brucei gambiense cAMP-specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 661 aa 30.3 %
Drosophila melanogaster Phosphodiesterase 6 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 684 aa 32.2 %
Trichomonas vaginalis cGMP-inhibited 3,5-cyclic phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 668 aa 24.7 %
Trypanosoma brucei cAMP-specific phosphodiesterase cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 666 aa 30.5 %
Leishmania mexicana cAMP specific phosphodiesterase, putative cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 671 aa 30.8 %
Echinococcus granulosus dual 3'5' cyclic AMP and GMP phosphodiesterase cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A   794 aa 686 aa 29.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Brugia malayi glutamate-cysteine ligase modifier subunit 0.0176 0.1704 0.0325
Plasmodium vivax oxidoreductase, aldo/keto reductase domain containing protein 0.0176 0.1704 0.5
Loa Loa (eye worm) hypothetical protein 0.0297 0.4053 0.3065
Entamoeba histolytica aldose reductase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase 0.0606 1 1
Trypanosoma brucei prostaglandin f synthase 0.0606 1 1
Echinococcus granulosus aldo keto reductase 0.0606 1 1
Echinococcus granulosus aldehyde reductase 0.0431 0.6617 0.5922
Loa Loa (eye worm) glutamate-cysteine ligase modifier subunit 0.0176 0.1704 0.0325
Loa Loa (eye worm) hypothetical protein 0.0256 0.3261 0.2142
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase 0.0606 1 1
Loa Loa (eye worm) oxidoreductase 0.0606 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Onchocerca volvulus 0.0606 1 1
Loa Loa (eye worm) oxidoreductase 0.0606 1 1
Mycobacterium tuberculosis Conserved protein 0.0176 0.1704 0.1704
Schistosoma mansoni aldo-keto reductase 0.0606 1 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0606 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Schistosoma mansoni potassium channel beta 0.0176 0.1704 0.0325
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Plasmodium vivax aldehyde reductase, putative 0.0176 0.1704 0.5
Onchocerca volvulus 0.0606 1 1
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative 0.0313 0.4358 0.3421
Leishmania major aldo-keto reductase-like protein 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0176 0.1704 0.1442
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Mycobacterium ulcerans oxidoreductase 0.0606 1 1
Trypanosoma brucei aldo-keto reductase, putative 0.0606 1 1
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic 0.0313 0.4358 0.32
Brugia malayi NADH-dependent xylose reductase 0.0176 0.1704 0.0325
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Loa Loa (eye worm) oxidoreductase 0.0606 1 1
Echinococcus granulosus aldo keto reductase 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Echinococcus granulosus hypothetical protein 0.0606 1 1
Loa Loa (eye worm) oxidoreductase 0.0606 1 1
Trypanosoma cruzi aldo-keto reductase 0.0606 1 1
Toxoplasma gondii aldose reductase, putative 0.0606 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Trichomonas vaginalis alcohol dehydrogenase, putative 0.0176 0.1704 0.1442
Loa Loa (eye worm) oxidoreductase 0.0606 1 1
Entamoeba histolytica aldose reductase, putative 0.0606 1 1
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic 0.0313 0.4358 0.32
Trichomonas vaginalis aldo/keto reductase, putative 0.0606 1 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0606 1 1
Trichomonas vaginalis aldo/keto reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Plasmodium falciparum aldehyde reductase, putative 0.0176 0.1704 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0176 0.1704 0.1442
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Entamoeba histolytica aldose reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0176 0.1704 0.1442
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.0606 1 1
Onchocerca volvulus 0.0606 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0176 0.1704 0.1442
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0606 1 1
Onchocerca volvulus 0.0606 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Onchocerca volvulus 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase 0.0606 1 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0606 1 1
Onchocerca volvulus 0.0606 1 1
Mycobacterium leprae Conserved hypothetical protein 0.0431 0.6617 0.5922
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0606 1 1
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.0606 1 1
Schistosoma mansoni pol-related 0.0606 1 1
Leishmania major prostaglandin f synthase, putative 0.0606 1 1
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0606 1 1
Trichomonas vaginalis aldo/keto reductase, putative 0.0606 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0606 1 1
Echinococcus multilocularis aldehyde reductase 0.0431 0.6617 0.5922
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Loa Loa (eye worm) hypothetical protein 0.0606 1 1
Echinococcus granulosus aldo keto reductase 0.0606 1 1
Giardia lamblia Aldose reductase 0.0606 1 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0606 1 1
Trypanosoma cruzi aldo/keto reductase, putative 0.0606 1 1
Giardia lamblia Aldose reductase 0.0606 1 0.5
Plasmodium falciparum aldo-keto reductase, putative 0.0176 0.1704 0.5
Mycobacterium ulcerans hypothetical protein 0.0176 0.1704 0.1704
Schistosoma mansoni aldo-keto reductase 0.0606 1 1
Echinococcus multilocularis aldo keto reductase 0.0606 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 24 nM Inhibition of human recombinant PDE2A expressed in Sf9 cells by scintillation proximity assay ChEMBL. 23260348
IC50 (binding) = 47 nM Inhibition of rat PDE10A expressed in Sf9 cells by scintillation proximity assay ChEMBL. 23260348

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.